T-cell receptor and co-stimulatory molecules (TCR and co-stimulatory molecules)

The T-cell receptor (TCR) is a multisubunit complex expressed on the surface of T lymphocytes, responsible for recognizing peptide antigens bound to major histocompatibility complex (MHC) molecules presented by antigen-presenting cells. Upon antigen recognition, the TCR transduces signals through CD3 subunits to initiate T-cell activation. Full T-cell activation, however, requires additional signals from co-stimulatory molecules, such as CD28, ICOS, and OX40, which augment or inhibit signaling pathways and thereby regulate the functional outcome of TCR engagement. These molecules collectively determine T-cell proliferation, survival, cytokine secretion, differentiation, and tolerance. Dysfunction or therapeutic targeting of these pathways underlies key strategies for cancer immunotherapy, treatment of autoimmune diseases, transplantation tolerance, and modulation of immune responses in infection[1][6][2][7][8]. Note: This entry covers an "axis" or "functional unit" rather than one protein/gene—a more precise canonical form would list each TCR chain (e.g., "T-cell receptor alpha chain"), each CD molecule (e.g., CD28), or each checkpoint molecule (e.g., PD-1) individually for structured datasets[6][8].

Other names

TCR complex and co-stimulatory receptorsTCR and co-signaling molecules

Blockade of inhibitory co-receptors (prevents T-cell suppression, e.g., PD-1/PD-L1, CTLA-4); Enhancement of co-stimulatory signals (agonists, e.g., anti-CD28, OX40, 4-1BB antibodies); Modulation of T-cell activation threshold and function[1][6]